Schrodinger Inc. Stock News

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its second quarter 202

Schrödinger and Recursion Pharmaceuticals use AI to improve drug development. Neither one has proven its business model to be viable yet.

Schrödinger's stock is riding the surge of interest in AI. Its drug discovery software is already bringing in money.

Goldman Sachs recently asserted “that AI adoption could boost productivity growth by 1.5 percentage points per year over a 10-year period.” The venerable firm's estimate shows how tremendously

Regional Banks have all the characteristics of Schrodinger's Cat. They appear phenomenally cheap on current earnings. They are dead in the water when you price in a reasonable cost of funds.

Although a topic that arouses myriad emotions, targeting overvalued stocks to sell represents an important component of investing strategy. Since we're in the middle of baseball season, you can't alwa

Schrödinger focuses on drug discovery using an AI platform. The company has already helped bring two therapies to market.

Finding early-stage, revolutionary companies whose market capitalizations can reach $1 trillion can be very lucrative. Just look atAlphabet (NASDAQ:  GOOG, NASDAQ: GOOGL ), Apple (NASDAQ: AAPL ), and

Schrodinger, Inc. (SDGR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price in

A Deloitte report about artificial intelligence (AI) in the life sciences puts it bluntly. Big data is the new currency for biopharma firms.

Despite a slight drop in software sales in 1Q23, attributed to timing issues with multi-year agreements, management revised guidance positively. I am optimistic about the software platform in the latt

Artificial intelligence is becoming an important value-add for collaborations. Some companies are pursuing collaboration-targeted business models.

A few recent news stories highlight the tremendous power of artificial intelligence to improve our world and boost business performance. A doctor says that the technology can be a key means of enabl

While the recent slow activity in the major indices clouds the narrative, you can still enjoy opportunities for growth stocks that could double your money. To be sure, you must be willing to accept so

With short sellers viciously attacking many popular stocks and Wall Street worrying too much about the macroeconomic outlook, there are a multitude of undervalued growth stocks for investors to buy n